Related Experiment Video
Updated: Aug 14, 2026

13:00
A Rapid High-throughput Method for Mapping Ribonucleoproteins (RNPs) on Human pre-mRNA
Published on: December 2, 2009
Rational drug design and high-throughput techniques for RNA targets
1Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. Thermann@sbnmr1.ski.mskcc.org
Combinatorial Chemistry & High Throughput Screening
|July 21, 2000
Summary
Ribonucleic acid (RNA) molecules carry genetic information and act as catalysts. Their structural complexity and interactions make them promising targets for drug discovery and development.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Discovery
Background:
- Ribonucleic acid (RNA) molecules uniquely combine genetic information storage, similar to DNA, with catalytic functions, akin to protein enzymes.
- RNA plays crucial roles in gene expression and various biological processes, achieving functions through complex three-dimensional structures.
- RNA sequences contain specific signatures for three-dimensional motifs involved in molecular recognition and binding.
Purpose of the Study:
- To explore the potential of RNA molecules as versatile drug targets.
- To highlight the different levels at which RNA can be targeted for therapeutic intervention.
- To discuss existing methods for identifying and developing drugs against RNA targets.
Main Methods:
- Analysis of RNA structural motifs and their relation to function.
- Investigation of RNA's role in regulatory pathways and its structural dynamics.
- Review of combinatorial synthesis and high-throughput screening techniques for drug discovery.
Main Results:
- RNA molecules exhibit potential as drug targets at the level of their three-dimensional folds, structural equilibria, and RNA-protein interfaces.
- Specific sequence signatures correlate with functional three-dimensional motifs in RNA.
- RNA structural dynamics and interactions are modulated by effectors like proteins and cofactors.
Conclusions:
- RNA's dual role as genetic material and catalyst, coupled with its structural complexity, presents multiple avenues for therapeutic targeting.
- Understanding RNA's structural intricacies and dynamic equilibria is key to developing novel drugs.
- Advanced screening and synthesis techniques are vital for discovering and developing RNA-targeted therapeutics.
Related Concept Videos
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

